BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 26511035)

  • 1. Generation of a miniature pig disease model for human Laron syndrome.
    Cui D; Li F; Li Q; Li J; Zhao Y; Hu X; Zhang R; Li N
    Sci Rep; 2015 Oct; 5():15603. PubMed ID: 26511035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation of GHR-modified pigs as Laron syndrome models via a dual-sgRNAs/Cas9 system and somatic cell nuclear transfer.
    Yu H; Long W; Zhang X; Xu K; Guo J; Zhao H; Li H; Qing Y; Pan W; Jia B; Zhao HY; Huang X; Wei HJ
    J Transl Med; 2018 Feb; 16(1):41. PubMed ID: 29482569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth hormone receptor-deficient pigs resemble the pathophysiology of human Laron syndrome and reveal altered activation of signaling cascades in the liver.
    Hinrichs A; Kessler B; Kurome M; Blutke A; Kemter E; Bernau M; Scholz AM; Rathkolb B; Renner S; Bultmann S; Leonhardt H; de Angelis MH; Nagashima H; Hoeflich A; Blum WF; Bidlingmaier M; Wanke R; Dahlhoff M; Wolf E
    Mol Metab; 2018 May; 11():113-128. PubMed ID: 29678421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transgenic Wuzhishan minipigs designed to express a dominant-negative porcine growth hormone receptor display small stature and a perturbed insulin/IGF-1 pathway.
    Li F; Li Y; Liu H; Zhang X; Liu C; Tian K; Bolund L; Dou H; Yang W; Yang H; Staunstrup NH; Du Y
    Transgenic Res; 2015 Dec; 24(6):1029-42. PubMed ID: 26510874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A mammalian model for Laron syndrome produced by targeted disruption of the mouse growth hormone receptor/binding protein gene (the Laron mouse).
    Zhou Y; Xu BC; Maheshwari HG; He L; Reed M; Lozykowski M; Okada S; Cataldo L; Coschigamo K; Wagner TE; Baumann G; Kopchick JJ
    Proc Natl Acad Sci U S A; 1997 Nov; 94(24):13215-20. PubMed ID: 9371826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary growth hormone (GH) insensitivity and insulin-like growth factor deficiency caused by novel compound heterozygous mutations of the GH receptor gene: genetic and functional studies of simple and compound heterozygous states.
    Fang P; Riedl S; Amselem S; Pratt KL; Little BM; Haeusler G; Hwa V; Frisch H; Rosenfeld RG
    J Clin Endocrinol Metab; 2007 Jun; 92(6):2223-31. PubMed ID: 17405847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional changes of the liver in the absence of growth hormone (GH) action - Proteomic and metabolomic insights from a GH receptor deficient pig model.
    Riedel EO; Hinrichs A; Kemter E; Dahlhoff M; Backman M; Rathkolb B; Prehn C; Adamski J; Renner S; Blutke A; de Angelis MH; Bidlingmaier M; Schopohl J; Arnold GJ; Fröhlich T; Wolf E
    Mol Metab; 2020 Jun; 36():100978. PubMed ID: 32277923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of GHR Deficiency and Juvenile Hypoglycemia on Immune Cells of a Porcine Model for Laron Syndrome.
    Schilloks MC; Giese IM; Hinrichs A; Korbonits L; Hauck SM; Wolf E; Deeg CA
    Biomolecules; 2023 Mar; 13(4):. PubMed ID: 37189345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Growth hormone insensitivity syndrome caused by a heterozygous GHR mutation: phenotypic variability owing to moderation by nonsense-mediated decay.
    Gorbenko del Blanco D; de Graaff LC; Visser TJ; Hokken-Koelega AC
    Clin Endocrinol (Oxf); 2012 May; 76(5):706-12. PubMed ID: 22117696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MECHANISMS IN ENDOCRINOLOGY: Transient juvenile hypoglycemia in growth hormone receptor deficiency - mechanistic insights from Laron syndrome and tailored animal models.
    Hinrichs A; Renner S; Bidlingmaier M; Kopchick JJ; Wolf E
    Eur J Endocrinol; 2021 Jul; 185(2):R35-R47. PubMed ID: 34048365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth Hormone Receptor Mutations Related to Individual Dwarfism.
    Lin S; Li C; Li C; Zhang X
    Int J Mol Sci; 2018 May; 19(5):. PubMed ID: 29748515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. First use of gene therapy to treat growth hormone resistant dwarfism in a mouse model.
    Sia KC; Gan SU; Mohd Rodhi SH; Fu ZY; Kopchick JJ; Waters MJ; Lee KO
    Gene Ther; 2022 Jun; 29(6):346-356. PubMed ID: 35105948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and Molecular Features of Laron Syndrome, A Genetic Disorder Protecting from Cancer.
    Janecka A; Kołodziej-Rzepa M; Biesaga B
    In Vivo; 2016; 30(4):375-81. PubMed ID: 27381597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Compound heterozygosity for two GHR missense mutations in a patient affected by Laron Syndrome: a case report.
    Moia S; Tessaris D; Einaudi S; de Sanctis L; Bona G; Bellone S; Prodam F
    Ital J Pediatr; 2017 Oct; 43(1):94. PubMed ID: 29025428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth hormone insensitivity and adipose tissue: tissue morphology and transcriptome analyses in pigs and humans.
    Young JA; Hinrichs A; Bell S; Geitgey DK; Hume-Rivera D; Bounds A; Soneson M; Laron Z; Yaron-Shaminsky D; Wolf E; List EO; Kopchick JJ; Berryman DE
    Pituitary; 2023 Dec; 26(6):660-674. PubMed ID: 37747600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical, Endocrine, and Molecular Genetic Analysis of a Large Cohort of Saudi Arabian Patients with Laron Syndrome.
    Al-Ashwal AA; Al-Sagheir A; Ramzan K; Al-Owain M; Allam R; Qari A; Al-Numair NS; Imtiaz F
    Horm Res Paediatr; 2017; 88(2):119-126. PubMed ID: 28743110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum IGF-1 is insufficient to restore skeletal size in the total absence of the growth hormone receptor.
    Wu Y; Sun H; Basta-Pljakic J; Cardoso L; Kennedy OD; Jasper H; Domené H; Karabatas L; Guida C; Schaffler MB; Rosen CJ; Yakar S
    J Bone Miner Res; 2013 Jul; 28(7):1575-86. PubMed ID: 23456957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The growth hormone receptor (GHR) c.899dupC mutation functions as a dominant negative: insights into the pathophysiology of intracellular GHR defects.
    Derr MA; Aisenberg J; Fang P; Tenenbaum-Rakover Y; Rosenfeld RG; Hwa V
    J Clin Endocrinol Metab; 2011 Nov; 96(11):E1896-904. PubMed ID: 21900382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tissue-specific regulation of growth hormone (GH) receptor and insulin-like growth factor-I gene expression in the pituitary and liver of GH-deficient (lit/lit) mice and transgenic mice that overexpress bovine GH (bGH) or a bGH antagonist.
    Iida K; Del Rincon JP; Kim DS; Itoh E; Nass R; Coschigano KT; Kopchick JJ; Thorner MO
    Endocrinology; 2004 Apr; 145(4):1564-70. PubMed ID: 14726438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel growth hormone receptor gene mutation in a patient with Laron syndrome.
    Arman A; Yüksel B; Coker A; Sarioz O; Temiz F; Topaloglu AK
    J Pediatr Endocrinol Metab; 2010 Apr; 23(4):407-14. PubMed ID: 20583548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.